Foreign body infections due to Staphylococcus epidermidis

Area of Science:

• Microbiology
• Infectious Diseases
• Biomaterials Science

Background:

• Staphylococcal infections, particularly Staphylococcus epidermidis, are a major complication in patients with implanted foreign prosthetic material.
• Biofilm formation by S. epidermidis on implants leads to significant antibiotic resistance, with a 1000-fold increase in minimal bactericidal levels for most antibiotics.
• Current treatment often requires removal of the implant, posing a significant clinical challenge.

Purpose of the Study:

• To review the pathogenesis, prevention, and treatment of implant infections caused by Staphylococcus epidermidis.
• To highlight emerging therapeutic strategies and novel compounds for managing these infections.
• To emphasize the need for a deeper understanding of biofilm-grown S. epidermidis.

Main Methods:

• Literature review focusing on pathogenesis, prevention, and treatment of S. epidermidis implant infections.
• Analysis of existing and novel therapeutic approaches, including antibiotic combinations and high-concentration in situ administration.
• Evaluation of in vitro data for new antibacterial compounds targeting biofilm-grown bacteria.

Main Results:

• S. epidermidis readily forms biofilms on implants, conferring high-level antibiotic resistance.
• Effective strategies include rifampin combinations, high local antibiotic concentrations, and early intervention before biofilm maturation.
• Several new compounds show promising in vitro activity against biofilm-grown S. epidermidis.

Conclusions:

• Managing S. epidermidis implant infections requires innovative approaches beyond simple antibiotic therapy.
• Further research into the mechanisms of biofilm resistance is crucial for developing next-generation antibacterial agents.
• Targeting biofilm formation and resistance pathways holds promise for improved treatment outcomes without device explantation.